JP2011517447A5 - - Google Patents

Download PDF

Info

Publication number
JP2011517447A5
JP2011517447A5 JP2011501758A JP2011501758A JP2011517447A5 JP 2011517447 A5 JP2011517447 A5 JP 2011517447A5 JP 2011501758 A JP2011501758 A JP 2011501758A JP 2011501758 A JP2011501758 A JP 2011501758A JP 2011517447 A5 JP2011517447 A5 JP 2011517447A5
Authority
JP
Japan
Prior art keywords
antibody
amino acid
seq
acid residues
variable domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011501758A
Other languages
English (en)
Japanese (ja)
Other versions
JP5823858B2 (ja
JP2011517447A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/011620 external-priority patent/WO2009120178A1/en
Publication of JP2011517447A publication Critical patent/JP2011517447A/ja
Publication of JP2011517447A5 publication Critical patent/JP2011517447A5/ja
Application granted granted Critical
Publication of JP5823858B2 publication Critical patent/JP5823858B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011501758A 2008-03-26 2008-10-08 抗vegf抗体 Active JP5823858B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3971908P 2008-03-26 2008-03-26
US61/039,719 2008-03-26
PCT/US2008/011620 WO2009120178A1 (en) 2008-03-26 2008-10-08 Anti-vegf antibody

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014102751A Division JP2014205674A (ja) 2008-03-26 2014-05-16 抗vegf抗体

Publications (3)

Publication Number Publication Date
JP2011517447A JP2011517447A (ja) 2011-06-09
JP2011517447A5 true JP2011517447A5 (enExample) 2011-11-24
JP5823858B2 JP5823858B2 (ja) 2015-11-25

Family

ID=41114205

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011501758A Active JP5823858B2 (ja) 2008-03-26 2008-10-08 抗vegf抗体
JP2014102751A Pending JP2014205674A (ja) 2008-03-26 2014-05-16 抗vegf抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014102751A Pending JP2014205674A (ja) 2008-03-26 2014-05-16 抗vegf抗体

Country Status (9)

Country Link
US (2) US7803371B2 (enExample)
EP (1) EP2259795B1 (enExample)
JP (2) JP5823858B2 (enExample)
KR (1) KR101581244B1 (enExample)
CN (2) CN103992405B (enExample)
AU (1) AU2008353479B2 (enExample)
BR (1) BRPI0822556B1 (enExample)
CA (3) CA2719400C (enExample)
WO (1) WO2009120178A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20241467T1 (hr) 2008-06-25 2025-01-03 Novartis Ag Stabilna i topljiva protutijela koja inhibiraju vegf
CN102002104A (zh) * 2009-08-28 2011-04-06 江苏先声药物研究有限公司 一种抗vegf的单克隆抗体及含有该抗体的药物组合物
CN102686609A (zh) * 2009-10-23 2012-09-19 加文医学研究所 修饰的可变域分子及其生产和使用方法
JP6097702B2 (ja) * 2011-03-03 2017-03-15 アペクシジェン, インコーポレイテッド 抗il−6受容体抗体およびその使用方法
CN103087192B (zh) * 2011-11-02 2015-02-04 埃派斯进有限公司 抗-kdr抗体和使用方法
CN103417965B (zh) * 2012-05-17 2018-04-13 江苏先声药业有限公司 一种含有抗vegf抗体的药物组合物
CN103417964A (zh) * 2012-05-17 2013-12-04 江苏先声药物研究有限公司 一种抗vegf抗体的用途
MY199344A (en) 2013-02-18 2023-10-24 Vegenics Pty Ltd Ligand binding molecules and uses thereof
CN105263959A (zh) * 2013-12-31 2016-01-20 财团法人生物技术开发中心 抗vegf抗体及其用途
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
GB201412658D0 (en) 2014-07-16 2014-08-27 Ucb Biopharma Sprl Molecules
WO2016115521A1 (en) * 2015-01-16 2016-07-21 Alder Biopharmaceuticals, Inc. Anti-glycoprotein antibodies and uses thereof
MX2017015908A (es) * 2015-07-06 2018-03-15 Ucb Biopharma Sprl Anticuerpos de union a tau.
GB201601073D0 (en) 2016-01-20 2016-03-02 Ucb Biopharma Sprl Antibodies
GB201601077D0 (en) 2016-01-20 2016-03-02 Ucb Biopharma Sprl Antibody molecule
GB201521382D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Antibodies
GB201521389D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Method
KR20250057128A (ko) 2015-12-30 2025-04-28 코디악 사이언시스 인코포레이티드 항체 및 이의 접합체
US12071476B2 (en) 2018-03-02 2024-08-27 Kodiak Sciences Inc. IL-6 antibodies and fusion constructs and conjugates thereof
WO2021046653A1 (en) * 2019-09-13 2021-03-18 Centre For Drug Research And Development Anti-oncolytic virus antigen antibodies and methods of using same
AU2020364071A1 (en) 2019-10-10 2022-05-26 Kodiak Sciences Inc. Methods of treating an eye disorder
EP4642805A4 (en) * 2022-12-29 2026-04-22 Ltz Therapeutics Inc Anti-cd79b antibodies and uses thereof
CN118344476B (zh) * 2024-05-16 2024-11-15 武汉爱博泰克生物科技有限公司 人c反应蛋白单克隆抗体、抗体对和检测试剂或试剂盒及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL145941A (en) * 1999-04-28 2007-08-19 Univ Texas Compositions and methods for cancer treatment by selectively inhibiting vegf
CN1299833A (zh) * 1999-12-30 2001-06-20 华西医科大学口腔医学研究所 抗人血管内皮生长因子单链抗体及其制备方法
US20040185040A1 (en) * 2001-11-21 2004-09-23 Celltech R & D Limited Modulating immune responses
EP1539947A4 (en) * 2002-08-15 2006-09-06 Epitomics Inc HUMANIZED RABBIT ANTIBODIES
US20050033031A1 (en) * 2003-08-07 2005-02-10 Couto Fernando Jose Rebelo Do Methods for humanizing rabbit monoclonal antibodies
US7462697B2 (en) 2004-11-08 2008-12-09 Epitomics, Inc. Methods for antibody engineering
US7431927B2 (en) 2005-03-24 2008-10-07 Epitomics, Inc. TNFα-neutralizing antibodies
HUE038432T2 (hu) * 2008-06-25 2018-10-29 Esbatech Alcon Biomed Res Unit Nyúl antitestek humanizálása egy univerzális antitest keret alkalmazásával
CN102002104A (zh) * 2009-08-28 2011-04-06 江苏先声药物研究有限公司 一种抗vegf的单克隆抗体及含有该抗体的药物组合物

Similar Documents

Publication Publication Date Title
JP2014205674A5 (enExample)
JP2009225799A5 (enExample)
JP2013198490A5 (enExample)
JP2019054802A5 (enExample)
JP2020079252A5 (enExample)
RU2017134495A (ru) Антитела к альфа-рецептору собачьего интерлейкина-4
JP2012010714A5 (enExample)
JP2015504421A5 (enExample)
JP2011518125A5 (enExample)
JP2017514461A5 (enExample)
JP2014526898A5 (enExample)
JP2013519364A5 (enExample)
JP2011173884A5 (enExample)
AU2016204274A1 (en) Antibodies that bind to OX40 and their uses
IL290591B1 (en) Antibody drug conjugates (adc) that bind to 191p4d12 proteins
JP2010534478A5 (enExample)
JP2013538057A5 (enExample)
JP2010536384A5 (enExample)
RU2017114341A (ru) Антитела к pd-l1, связывающие pd-l1 собаки
JP2012525829A5 (enExample)
NZ703035A (en) Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
PE20081185A1 (es) Anticuerpos que se unen a interleucina 13 (il-13) humana y composiciones farmaceuticas que lo comprenden
JP2012524071A5 (enExample)
JP2016516400A5 (enExample)
JP2011518546A5 (enExample)